SOURCE: Solos Endoscopy, Inc.

January 04, 2007 08:31 ET

Solos Endoscopy, Inc. Further Extends Qualifying Date for Shareholders Participating in the Stock Exchange Program

BOSTON, MA -- (MARKET WIRE) -- January 4, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) is pleased to announce that the Company has further extended the date that participants of the share exchange program need to have their shares to the Company's transfer agent. Solos Endoscopy, Inc. has offered to exchange common shares of stock from shareholders in exchange for convertible preferred stock to be valued at $0.50 a share. Current shareholders must now have their shares into Florida Atlantic Stock Transfer by January 12, 2007, rather than January 5, 2007, in order to qualify for the exchange of common shares to preferred convertible shares. This is due to the unanticipated closing of the stock market for President Ford's funeral.

For every one share of Solos Endoscopy, Inc. that eligible shareholders turn into Florida Atlantic Stock Transfer by the deadline, the shareholders will receive one share of preferred convertible stock valued at $0.50 per share. The preferred shares, following a one-year holding period, can then be converted back to restricted common shares at a dollar for dollar exchange. Shareholders must be of record as of December 20th, 2006 and must turn in a minimum of 1000 shares in order to qualify. The convertible preferred stock will be protected from any future stock restructuring by the Company.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information